Matthew Duvernay

Matthew Duvernay

Company: Cartesian Therapeutics

Job title: Director - Research


RNA Cell Therapy in Autoimmune Diseases & Cancer 12:00 pm

RNA cell therapy harnesses the best traits of conventional RNA and DNA-based cell therapy while eliminating their worst. By engineering primary human cells with RNA, there is no concern of immunogenicity induced by RNA or its carrier. The activity of the engineered gene can be controlled by the RNA’s natural half-life conferring a high level…Read more

day: Pre-Conference Focus Day

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.